US FDA Warns Foreign Manufacturers Of OTC Analgesics For Monograph Non-Compliance
Executive Summary
Malaysia-based Furley Bioextracts and Honduras-based Laboratorio Pharma International receive warning letters from the US FDA following import alerts in May and June for marketing products as OTC analgesic drugs without complying with controlling monograph conditions.